Table of Contents

company-logo

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

ArriVent BioPharma Dividend Announcement

• ArriVent BioPharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on ArriVent BioPharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ArriVent BioPharma Dividend History

ArriVent BioPharma Dividend Yield

ArriVent BioPharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ArriVent BioPharma stock? Use our calculator to estimate your expected dividend yield:

ArriVent BioPharma Financial Ratios

P/E ratio-15.36
PEG ratio-0.15
P/B ratio3.88
ROE-31.95%
Payout ratio0.00%
Current ratio25.50
Quick ratio25.50
Cash Ratio24.69

ArriVent BioPharma Dividend FAQ

Does ArriVent BioPharma stock pay dividends?
ArriVent BioPharma does not currently pay dividends to its shareholders.
Has ArriVent BioPharma ever paid a dividend?
No, ArriVent BioPharma has no a history of paying dividends to its shareholders. ArriVent BioPharma is not known for its dividend payments.
Why doesn't ArriVent BioPharma pay dividends?
There are several potential reasons why ArriVent BioPharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ArriVent BioPharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ArriVent BioPharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ArriVent BioPharma a dividend aristocrat?
ArriVent BioPharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ArriVent BioPharma a dividend king?
ArriVent BioPharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ArriVent BioPharma a dividend stock?
No, ArriVent BioPharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ArriVent BioPharma stocks?
To buy ArriVent BioPharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ArriVent BioPharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.